Trainee's view

Anand Jain

Anand Jain, MD, Head of Clinical, Medical, Regulatory affairs and Quality Assurance at Novo Nordisk Pharma, Malaysia

“I have gone through a couple of the e-learning modules of PharmaTrain. They are extremely informative and conveniently interactive. Unlike others, these modules get us engaged and seek our active participation. I look forward for taking more of such e-learning modules.”

_______________________________________________________________
Enkelejda Miho

Enkelejda Miho, Department of Biosystems Science and Engineering, ETH Zürich, Switzerland

Widen my international network with fascinating individuals
“The e-module “Full Development of a Biological” provides an overview on therapeutic monoclonal antibodies (mAbs). It efficiently introduces the basic biology and allows in-depth understanding of latest updates in research and clinical development. It is very useful for a complete prospective of discovery and development of mAbs.”

_______________________________________________________________
Susanne Haefliger

Susanne Haefliger, DVM, Takeda Pharma AG

Widen my international network with fascinating individuals
“I grew up in Hong Kong and studied veterinary medicine at the University of Zurich. I completed a lot of stages in foreign countries and practiced as a vet for four years. I then switched to the pharma industry. That’s five years ago. My basic motivation for a training was to keep up-to-date in the business and intensify my knowledge in medical development including health care surroundings and politics, registry, clinical trials, health care economics etc. During the training you get an impression of what authority people think and what the trend is in health care and industry. While starting I also recognised the potential to widen my international network with fascinating individuals of a great variety of backgrounds. My intention was not a career plan but of course I am open for next steps. As the course is not for free the training needs to be effective and focused. In my opinion standardisation of education throughout Europe and beyond is of great value because there are a lot of universities offering similar trainings. So if the brand PharmaTrain is known and recognised, courses are valued as standardised high-quality trainings within the industry and the certification gets a higher impact. ”

_______________________________________________________________
Michael Weisskopf

Michael Weisskopf, Clinical Trial Centre University Hospital Zurich

A key criterion: international course reputation
“After studying medicine at the University of Zurich and two years as a resident in internal medicine I joined the Clinical Trial Center at the University Hospital of Zurich. During the last three years I was involved in the planning and conduct of academic and industry supported clinical trials as well as in the education and consulting of scientists and investigators. In order to get the whole picture of drug development and a better understanding of the industry requirements I joined the course to complete the further education and achieve the FMH Specialist Title in Pharmaceutical Medicine. A key criterion for choosing the course was its reputation within academia as well as within industry – this on an international level. To bring the worlds of academia and industry together is of utmost importance for successful clinical research. My vision is to play a relevant role in this interface and to contribute to a fruitful collaboration between investigators, clinicians and industry. ”

_______________________________________________________________
Isabelle Widmer

Isabelle Widmer, Medical Information Harmonization Leader Western Europe, Roche

Need for internationally accredited course content
“I’m an MD with postgraduate training in experimental Medicine. I worked in basic oncology research and as a clinician before joining the industry in medical affairs. My motivation for taking a Master Programme was to get a unique overview of pharmaceutical industry including new areas. My goal in taking the course was to drive my understanding, not my career. Nevertheless I enjoyed unexpected benefits by exposure to new content and to individuals with different backgrounds, and I identified areas of interest for next steps in my professional development. In todays rapidly evolving job market flexibility and staying abreast of developments are key. As the world becomes smaller, individuals increasingly relocate and teams are spread across geographic locations there is a growing need for training courses providing standardized and internationally accredited content. Individuals need to be sure that their training will be recognized regardless of where they end up working and standardized training courses for pharma will help facilitate a consistent approach within a team regardless of geographic location.”

_______________________________________________________________
rajesh.jpg

Yan Liu, Brussels

“I completed my medical studies in China. After two years as a resident radiologist in the imaging diagnosis centre at the Shanghai Children’s Medical Centre I moved to Brussels to study neonatal brain structure. While finalizing my PhD I started the Pharmed course in October 2011 that will end in December this year. I have learned something new besides my specialization and transferred my knowledge into the expertise of medicines development. I recently accepted a position as Head of the Translational Research, Radiotherapy, and Imaging Department at the European Organisation for Research and Treatment of Cancer (EORTC). My responsibility is to integrate translational research and imaging more fluidly into EORTC clinical trials. For 2013 I plan together with colleagues from the Pharmed course to continue the studies at King’s Collage in London to get a Masters degree. I am very happy that PharmaTrain has enabled that this step can be done without friction and on a high quality level.”

_______________________________________________________________
rajesh.jpg

Rajesh Chavhan from Pune, India works for Novartis Pharmaceuticals

“The European PharmaTrain platform offers all the competences to complete my skill set.”

_______________________________________________________________
patricia.jpg

Patricia Blank from Uni Zurich just signed up at the European Center of Pharmaceutical Medicine (ECPM)..

“I am interested to widen my knowledge and know-how in integrated medicines development. It should go beyond what I have studied and applied now during two years in a pharmaceutical company. I seek to shape my profile for the next career step.”

_______________________________________________________________
Torgovicky_Rafael_150x110.png

Rafael Torgovicky previously worked for Novartis and MSD. Right now he’s working as an independent consultant, and is leading the development of ICMP – the Israeli Center of Pharmaceutical Medicine – in Tel Aviv, in collaboration with PharmaTrain.

Ready to go for training excellence
“I graduated from ECPM on the class of 2011. It was a great learning experience in an international environment, which supplemented my industry experience, enabled me to meet colleagues from all around the world and expanded my network. Attending this program was a significant driver to my career.”

_______________________________________________________________
Solonets_Maria_150x110.png

Maria Solonets

“I graduated from ECPM in 2011. Participation in the course helped me with seeing “the whole picture” of drug development. When one works in certain area of drug development, one has good knowledge of his or her own area, such as drug safety or regulatory affairs or pre-clinical development. The course helped me to see the way of a new medicine from molecule screening until the registration and marketing. I then decided to continue with master course study. E-learning will now play a bigger role for me because it fits my restriction in time and traveling.”

_______________________________________________________________